European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.
Eivind Berge, William Whiteley, Heinrich Audebert...
https://pubmed.ncbi.nlm.nih.gov/33817340/Actively Recruiting
Led by ASST Santi Paolo e Carlo · Updated on 2024-12-17
400
Participants Needed
7
Research Sites
12 weeks
Total Duration
This research investigates patients with acute large-vessel occlusion stroke LVOS who undergo mechanical thrombectomy and rescue stenting when initial treatments fail. The study aims to understand real-world antithrombotic strategies used in emergency stenting, particularly in those treated with intravenous thrombolysis IVT, and to assess the safety of stenting after IVT. It addresses challenges such as recanalization failure and the uncertain timing of antiplatelet therapy after IVT. The study follows patients undergoing rescue stenting within 24 hours of stroke onset after thrombectomy. Researchers observe the antithrombotic treatments chosen in these emergency cases, including the use of glycoprotein IIbIIIa receptor inhibitors and dual antiplatelet therapy. No experimental interventions are assigned, as this is an observational study assessing current practices across multiple centers. Participants will be monitored for safety, focusing on the rate of symptomatic cerebral hemorrhage within 24 hours post-treatment, and their functional outcome at 3 months using the modified Rankin Scale. The study collects data on treatments, complications, and recovery outcomes over time to better understand the effectiveness and risks of rescue stenting after IVT. The total duration of participation varies according to follow-up schedules.
CONDITIONS
Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke
E
Elena Ballabio, Medical Doctor
L
Luca Valvassori, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
ASST Santi Paolo e Carlo
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 24 hours of stroke onset
Participants undergo diagnostic assessments related to stroke and vessel occlusion.
1 visit (in-person)
Duration - Within 24 hours of stroke onset
Participants receive rescue stenting and intravenous thrombolysis as part of their treatment for large vessel ischemic stroke.
1 treatment visit (in-person)
Duration - Up to 3 months
Participants are monitored for outcomes including symptomatic cerebral hemorrhage and functional status.
Follow-up visits up to 3 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Eivind Berge, William Whiteley, Heinrich Audebert...
https://pubmed.ncbi.nlm.nih.gov/33817340/Byung Hyun Baek, Woong Yoon, Yun Young Lee...
https://pubmed.ncbi.nlm.nih.gov/33793319/Nicholas D Osteraas, Richard W Crowley, Nicholas Panos...
https://pubmed.ncbi.nlm.nih.gov/32807436/William J Powers, Alejandro A Rabinstein, Teri Ackerson...
https://pubmed.ncbi.nlm.nih.gov/31662037/Donald V Heck, Morry D Brown
https://pubmed.ncbi.nlm.nih.gov/25387730/Marios Psychogios, Alex Brehm, Elena López-Cancio...
https://pubmed.ncbi.nlm.nih.gov/36082254/Ross Naylor, Barbara Rantner, Stefano Ancetti...
https://pubmed.ncbi.nlm.nih.gov/35598721/Guillaume Turc, Pervinder Bhogal, Urs Fischer...
https://pubmed.ncbi.nlm.nih.gov/30808653/Guillaume Turc, Georgios Tsivgoulis, Heinrich J Audebert...
https://pubmed.ncbi.nlm.nih.gov/35115395/Mayank Goyal, Bijoy K Menon, Wim H van Zwam...
https://pubmed.ncbi.nlm.nih.gov/26898852/ASST Santi Paolo e Carlo
Lead Sponsor